Equity Alerts Mar. 14th: Walgreen, Jabil Circuit, Infinity Pharma, Penske, Chevron

Walgreen Co. (NYSE:WAG): Credit Suisse believes a Walgreen’s (NYSE:WAG) acquisition of Rite Aid (NYSE:RAD) would make sense strategically given its contact dispute with Express Scripts (NASDAQ:ESRX) and CVS (NYSE:CVS) and reimbursement rate pressures. The firm said a potential transaction would create significant synergies and would unlikely raise major anti-trust concerns. The firm puts the odds of a deal at 1 in 3.

Jabil Circuit Inc. (NYSE:JBL): After conducting checks, RBC Capital believes that demand for Jabil’s products last quarter likely exceeded the company’s guidance. The firm increased its estimates and maintains an Outperform rating.

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI): Piper Jaffray raised its price target for Infinity Pharmaceuticals following the company’s Q4 results and reiterates an Overweight rating on the stock.

Penske Automotive Group, Inc. (NYSE:PAG): Sterne Agee raised its 2012 estimates for Penske, citing recent acquisitions, a lower share count and continued improvement in U.S. demand. The firm maintains a Buy rating.

Chevron Corp. (NYSE:CVX): Barclays continues to believe Chevron is undervalued vs. peers and reiterates its Overweight rating.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com